Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-12-22Clinical Trial Update: Graz Study on the Risk of Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update from the Medical University of Graz examining the risk of atrial fibrillation in patients with hypertension an…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: The Effect of Synching Prescription Refills on Adherence [NA]
The University of Pennsylvania clinical trial evaluated whether syncing prescription refills improves medication adherence in patients with …
-
CLINICAL_TRIALS research · 2015-12-22Clinical Trial Update: Study to Investigate Effects of Different Therapies for the Treatment of Hypertension [NA]
A multicenter clinical trial evaluating different therapies for hypertension has completed. The document does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: The Long Term Effect of Adjustable Spaatz 3 Intragastric Balloon on Weight Loss [NA]
A terminated long-term clinical trial evaluated the adjustable Spaatz 3 intragastric balloon for weight loss in obesity, with related condit…
-
FDA approval · 2015-12-21FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc., granting approval for chang…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-12-21FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
FDA approves Baxter's supplemental application for Cardene IV, an intravenous formulation of nicardipine hydrochloride. The new IV product e…
-
FDA approval · 2015-12-21FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a generic fixed-dose combination of amlodipine and valsartan. This appr…
-
FDA approval · 2015-12-21FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) submitted by Novartis, updating the product labeling…
-
FDA approval · 2015-12-21FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for amlodipine besylate from Cipla USA Inc., effectively approving a generic formulation of amlodipi…
-
FDA approval · 2015-12-21FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a generic amlodipine/valsartan/hydrochlorothiazide tablet for the treatment…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study [Phase 2]
A Phase 2 trial evaluates whether melatonin affects nighttime blood pressure in African American adults with hypertension; results have been…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Standardized Eucommia Extract in the Treatment of Hypertension [Phase 2]
This update reports the completion of a Phase 2 trial evaluating standardized Eucommia extract for hypertension.
-
FDA approval · 2015-12-18FDA Approved: NADOLOL — Original Application (Cipla USA Inc.)
FDA approved Nadolol from Cipla USA Inc. as an original generic application (ANDA). Nadolol is used for hypertension and to prevent esophage…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution [Phase 3]
Phase 3 trial results evaluating the acute effects of the ACE inhibitor enalaprilat on flow distribution were completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study [Phase 2]
Phase 2 trial evaluating whether 24 mg of melatonin can affect nighttime blood pressure in African Americans with hypertension; the study is…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Improving the Quality of Patient Care by Using a Clinical Expert System. [NA]
Completed trial evaluating a clinical expert system intended to improve patient care, with results posted.
-
FDA approval · 2015-12-17FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for LOTENSIN (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) [Phase 2]
Phase 2 trial update for patiromer in treating hyperkalemia in patients with hypertension and diabetic nephropathy (AMETHYST-DN) completed w…
-
FDA approval · 2015-12-17FDA Approved: VALSARTAN — Supplemental Application (Ohm Laboratories Inc.)
FDA approved a supplemental application for VALSARTAN from Ohm Laboratories Inc. (ANDA077492).
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Evaluating the Relationship Between Stress, Ethnicity, and Blood Pressure
A completed clinical trial investigated how stress levels and ethnicity may influence blood pressure in individuals with hypertension.
-
FDA approval · 2015-12-16FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for metoprolol succinate by Quallent Pharmaceuticals Health LLC, indicating approval of the suppleme…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Chlorthalidone and HCTZ Impacts on Platelet Activation [Phase 4]
Phase 4 clinical trial examining how chlorthalidone and hydrochlorothiazide affect platelet activation in patients with hypertension.
-
FDA approval · 2015-12-11FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approves a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) submitted by Organon LLC.
-
FDA approval · 2015-12-11FDA Approved: VALSARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for VALSARTAN submitted by Alembic Pharmaceuticals Limited.
-
FDA approval · 2015-12-10FDA Approved: AMLODIPINE BESYLATE — Original Application (Exelan Pharmaceuticals, Inc.)
FDA approves the Original Application for amlodipine besylate, a generic version of the calcium channel blocker used to treat hypertension a…